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Background The wide-ranging nature of state vaccination requirements for school entry allows for 
suboptimal coverage of adolescent vaccination as well as missed opportunities where some adolescent 
vaccinations are received but not all of them. Variation exists both in the types of exemptions that are 
allowed and the process that is required to obtain an exemption. State-level policies have been shown to 
be associated with childhood vaccination coverage, but far fewer studies have examined adolescent 
vaccine coverage. 
Methods HPV, MenACWY, and Tdap vaccine receipt and demographic data from the 2017 National 
Immunization Survey-Teen (NIS-Teen) Public Use Dataset were combined with data on school entry 
requirements and allowable exemptions from the Immunization Action Coalition. Ease of exemption was 
determined through ranking of exemption criteria collected from state immunization websites. Univariate 
logistic regressions and multivariable logistic regressions adjusting for demographic variables associated 
with vaccine outcomes were run to determine the relationship of missed opportunities and vaccine 
initiation with state vaccine policies. 
Results Having a vaccine requirement for a specific adolescent vaccine was associated with higher odds 
of initiating vaccination for that specific vaccine and lower odds of having a missed opportunity for that 
vaccine. However, there was no association between requirements for an adolescent vaccine and coverage 
for other non-targeted vaccines. While there were significant associations between the ease of exemption 
requirement outcomes and the number of mechanisms to obtain a non-medical exemption with some 
vaccination outcomes, there was not a consistent trend in the results.  
Conclusions The ease of obtaining a vaccine exemption seems to have less of an impact on adolescent 
vaccination than the presence of a school entry requirement does. Future research that seeks to understand 
the limited association between exemption policies and adolescent vaccination will be important to 
determine optimal state policies. School entry requirements still remain the strongest policy means for 
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In additional to annual influenza vaccination, there are three vaccines that are 
recommended to be given routinely to adolescents: the tetanus, diphtheria, and acellular pertussis 
vaccine (Tdap), recommended since 2005; the quadrivalent meningococcal vaccine 
(MenACWY), recommended as one dose since 2005 and recommended with a booster dose 
since 2010; and the human papillomavirus vaccine (HPV), recommended for females since 2006 
and males since 2011.1,2,3 To decrease incidence of these diseases, a goal was set in the Healthy 
People 2020 objectives to achieve 80% coverage of these vaccines. Though this goal has been 
met for the Tdap vaccine, with 88% coverage among 13 to 17-year-olds, and the MenACWY 
vaccine, with 82.2% of 13 to 17-year-olds having received at least one dose, for the HPV 
vaccine, up-to-date coverage is only at 43.4% among 13 to 17-year-olds.4  
HPV coverage has remained lower than the other adolescent vaccines for a number of 
reasons. One is the widespread lack of school entry requirements for the vaccine. Despite more 
than 10 years having passed since the initial recommendation of the vaccine, only 3 states and 
jurisdictions currently have school entry requirements, with some allowing for broad 
exemptions, and political pushback has prevented requirements being passed in other states.5 
Low HPV vaccination is also associated with provider and parent characteristics. Providers were 
less likely to perceive HPV vaccination as urgent and were less likely to take time to respond to 
parental pushback about the HPV vaccine while parents often cited lack of provider 
recommendations as a reason not to have their children receive the vaccine.6 
Because of the wide-ranging school entry requirements for adolescent vaccines, missed 
opportunities can occur where at least one of the three vaccines are administered to an eligible 
adolescent but the others are not at the same visit. These missed opportunities may be 
contributing to the lower coverage of HPV vaccination. A recent study in Kansas found of the 
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sixth and seventh graders who received the Tdap booster between 2013-2015, 53-82% did not 
receive an HPV vaccine and 36-47% did not receive a MenACWY vaccine at the same time.7 
Another study in Washington observed that 33% of eligible girls and 39% of eligible boys had at 
least one missed opportunity for HPV vaccine series initiation between 2006 and 2013.8  
Previous studies have lent some credence to using the expansion of school entry vaccine 
requirements as a possible strategy for increasing coverage and reducing missed opportunities. 
This would likely occur through both direct and spillover effects. One study found that states 
with Tdap booster and meningococcal school entry requirements were associated with larger 
spillover increases in HPV vaccination coverage while states that did have HPV vaccine school 
entry requirements saw no higher coverage than states that did not for the other adolescent 
vaccines.9 However, there is the possibility that the spillover effects may begin to diminish over 
time. 
Another possible strategy for increasing coverage and reducing missed opportunities is 
increasing the difficulty of the process of obtaining a non-medical exemption. While states have 
policies that require certain vaccines for school entry, most states also have policies that allow 
for non-medical exemptions to these requirements. Policies include both allowable exemption 
types (religious and/or philosophical) and different procedures for obtaining exemptions that 
vary in degree of difficulty to obtain. Some possible difficult procedures of obtaining a vaccine 
exemption include requiring notarization on the exemption form or needing to renew the 
exemption annually. In some states, it is easier to receive exemptions than meet the vaccine 
requirement.10 By assessing the ease of obtaining an exemption, we are able to examine how this 
may further impact a decision to opt out of HPV and/or MenACWY vaccination. 
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Studies of the association between exemption policies and their impact on coverage and 
missed opportunities have largely been focused on childhood vaccines but not adolescent 
vaccines. While there has been research showing an increased incidence of exemptions and of 
vaccine-preventable diseases in areas with more expansive exemption policies, they have been 
focused on vaccines given for kindergarteners, such as the measles vaccine.11,12 For adolescent 
vaccines, some research has been done to look at the impact of area-based factors influence HPV 
vaccination.13,14,15 One study did look at the impact of state HPV vaccine policies on HPV 
vaccine coverage, finding completion of HPV vaccine series was associated with having HPV 
vaccine school entry requirements while there was little variation in non-medical exemption 
types among the states with the highest and lowest HPV vaccine coverage.16 Exemption policies 
have largely not been explored in the realm of adolescent vaccines, though. 
This is one of the first studies to explore which components of state vaccine policies, 
including exemptions, have the greatest impact on increasing coverage and reducing missed 
opportunities. We hoped to assess what was the association between both overall coverage and 
missed opportunities for HPV and/or MenACWY vaccination, here defined as receipt of one of 
the adolescent vaccines, Tdap, MenACWY, or HPV, but not MenACWY or HPV, and various 
components of state vaccination policies, such as school entry vaccine requirements, allowable 
non-medical exemption types, and ease of receiving such an exemption.  
Our first hypothesis was that those residing in states that have vaccine requirement 
policies for MenACWY and/or HPV vaccination will be less likely to have a missed opportunity 
for HPV or MenACWY vaccination and more likely to have higher coverage. Our second 
hypothesis was that those residing in states that have easier means of getting an exemption for 
the other adolescent vaccines will be more likely to have lower coverage and have higher odds of 
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missing an opportunity for HPV or MenACWY vaccination compared to those residing in states 
with stricter requirements around getting exemptions. By combining these various factors, we 
hoped to provide a unique perspective to the larger discussion on how state requirements and 
exemptions could impact adolescent vaccination. 
Materials and Methods 
Data sources  
Immunization, demographic, and geographic data were collected from the public use data 
for the National Immunization Survey-Teen (NIS-Teen) from 2017, the latest year from which 
that data was publicly available. NIS-Teen is a cross-sectional population-based national survey. 
The target population is non-institutionalized adolescents aged 13-17 years living in United 
States households at the time of the interview. It consisted of two parts: a household telephone 
survey done through random digit dialing and a mail survey of vaccination providers named and 
approved to be contacted by those who answered the telephone survey. Each household provided 
information on a selected member between the ages of 13-17 years. Data were collected from the 
person deemed most knowledgeable about the selected household member’s vaccination history. 
Data were collected about each selected household member about self-reported vaccination 
histories, socioeconomic and demographic variables, geographic variables, number and 
characteristics of providers, and health insurance variables. Respondents were asked for 
permission to contact named vaccination providers. The public dataset includes 43,591 teens 
with 20,949 having adequate provider data. Target sample size of completed telephone 
interviews was chosen to have an equal coefficient of variation of 6.5% for an estimator of 
vaccination coverage, given a true coverage parameter of 50%. 48.2% were determined to have 
adequate provider data.17  
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Data about state school entry vaccine requirements and exemptions were publicly 
available through the Immunization Action Coalition, a non-profit organization that creates and 
distributes educational materials for both the public and healthcare professionals on 
immunizations.18  
Data management and analysis 
 The dataset was restricted to include those individuals who had adequate provider data. 
To ensure that this sample would be nationally representative, survey weighting was applied as 
described in the NIS-Teen User Guide for the 2017 Public Use Dataset.17 
 The two datasets (the 2017 NIS-Teen Public Use Dataset and data from the Immunization 
Action Coalition) were merged. An individual was listed as living in a state with a vaccine 
requirement for HPV, MenACWY, or MenACWY booster dose if a requirement was in place in 
their state of residence for the 2016-2017 school year that applied to students at all schools. A 
Tdap vaccine requirement was not included as every state had a school entry requirement. 
Individuals were also classified by the number of mechanisms for obtaining a non-medical 
exemption (religious and/or philosophical exemptions) in their states of residence that were in 
place for the 2016-2017 school year.  
The ease of exemption variable was created on a 3-point scale (easy, medium, difficult). 
Criteria for determining the ease of obtaining a vaccine exemption were adapted from the criteria 
used by Omer et al and were collected from state immunization websites and validated through 
comparison with data collected by the CDC Public Health Law Program.19,20 Criteria included if 
a letter needed to be written and submitted (compared to a form), if the form or letter needed to 
be returned to the health department (compared to the school), if a notarization or a signature 
from another individual (county official, health professional) is needed (compared to only a 
parent’s signature), and if annual renewal was required (compared to the exemption only needing 
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to be obtained once). Based on a similar ranking of criteria used to create an ease of exemption 
variable by Omer et al, we created a hierarchy of the criteria.11 Obtaining a notarization or 
signature from another individual was deemed the most difficult criteria, and any state with that 
criteria was classified as difficult. If a state had more than 1 of the remaining criteria, it was also 
classified as difficult. If a state met only 1 of the remaining criteria, it was classified as medium 
difficulty. If a state did not meet any of the criteria, it was classified as easy. A correlation test 
between this variable and the ease of exemption variable created by Omer et al found the two 
measures to be statistically significantly correlated (p<0.0001).11 Those residing in California, 
West Virginia, and Mississippi were excluded from analysis by this variable as these states do 
not offer non-medical exemptions. 
 An individual was defined to have initiated a vaccine (HPV, MenACWY, and Tdap) if 
they had received at least one provider-confirmed dose. Being up-to-date on HPV was defined as 
having 3 doses or having 2 doses with the first shot given before age 15 and having an interval 
between first and second shot of at least 5 months in year 2016 or later. 
An individual was defined as having a missed opportunity for MenACWY initiation if 
they have provider-confirmed receipt of initiation of HPV and/or Tdap vaccination but no 
provider-confirmed receipt of initiation of MenACWY vaccination. An individual was defined as 
having a missed opportunity for HPV initiation if they have provider-confirmed receipt of 
initiation of MenACWY and/or Tdap vaccination but no provider-confirmed receipt of initiation 
of HPV vaccination.    
Bivariate associations were assessed between demographic variables and policy variables 
with vaccine outcome variables using Wald chi-square tests. The demographic variables were 
those that have been found to be associated with vaccine initiation and completion in previous 
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studies (age of teen, mother’s age, mother’s education level, poverty status, marital status of 
mother, race/ethnicity, sex, health insurance status, facility type where vaccinations where given, 
census region, whether the teen had a check-up at 11 or 12, and whether the teen had a doctor’s 
visit in the last 12 months).15 Policy variables included whether the individual resided in a state 
with a meningitis vaccine requirement, whether the individual resided in a state with a meningitis 
booster vaccine requirement, whether the individual resided in a state with a HPV vaccine 
requirement, the number of mechanisms of obtaining a non-medical exemptions in an 
individual’s state of residence, and the ease of obtaining a vaccine exemption in their state of 
residence. Vaccine outcome variables included MenACWY vaccine initiation, HPV vaccine 
initiation, being up-to-date for HPV vaccination, Tdap vaccine initiation, having a missed 
opportunity for MenACWY vaccination, and having a missed opportunity for HPV vaccination. 
Missed opportunities for Tdap were not considered as every state has a requirement for this 
vaccine and less than 3% of the sample had a missed opportunity for Tdap (Results from 
bivariate analysis included in Supplemental Content). 
From there, logistic regression models were created to assess correlates of the vaccine 
outcome variables. For each outcome variable, a univariate logistic regression model was run 
using each policy variable as the predictor variable. From there, multivariate logistic regression 
models were run for each outcome using each policy variable as the predictor variable and 
adjusting for the demographic variables. The models produced odds ratio estimates (ORs) and 
95% confidence intervals (CIs).  
All data analysis was performed in SAS 9.4 using SAS survey functions and the sampling 
weighting for provider-verified data as described in the NIS-Teen User’s Guide for the 2017 





 Our sample of those with adequate provider-verified data totaled 20,949 individuals. 
There was a fairly even distribution of age and sex. The majority of the sample was non-
Hispanic white (52.3%), had private insurance only (50.5%), received all vaccinations at private 
facilities (53.4%), received a check-up at age 11 or 12 (95.1%), and had at least one health care 
visit in the past 12 months (84.2%). About half (55.9%) resided in a state with a MenACWY 
requirement while the majority resided in a state that did not have a MenACWY booster 
requirement (84.8%). The majority also resided in a state that did not have an HPV requirement 
(97.1%). The majority of the sample (52.5%) resided in a state that had one mechanism for non-
medical vaccine exemptions (religious or philosophical exemption). Based on our criteria, 27.5% 
of individuals resided in a state with easy exemption requirements, 15% in a state with medium 
difficulty exemption requirements, and 57.5% in a state with difficult exemption requirements 
(Table 1). 
Coverage 
After adjusting for all individual characteristics, it was found that those who resided in 
states with a MenACWY vaccine requirement was associated with higher odds of initiating 
MenACWY vaccination (aOR: 1.82, 95% CI: 1.53-2.18). Those residing in a state with an HPV 
vaccine requirement had higher odds of both initiating HPV vaccination (aOR: 2.43, 95% CI: 
1.64-3.61) and being up-to-date on HPV vaccination (aOR: 1.99, 95% CI: 1.04-3.80) compared 
to those residing in a state without an HPV vaccine requirement. No significant association was 
observed between residing in a state with a MenACWY booster dose requirement and 
MenACWY initiation.  
When looking at potential spillover effects, residence in a state with a MenACWY was 
associated with having lower odds of both initiating HPV vaccination and being up-to-date for 
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HPV vaccination. For the MenACWY booster dose requirement, residence in a state with such a 
requirement was associated with lower odds of initiating Tdap vaccination and being up-to-date 
for HPV vaccination compared to residence in a state without one. There was no association 
between residing in a state with a MenACWY booster dose requirement and HPV initiation as 
well as no association between residing in a state with an HPV vaccine requirement and 
MenACWY vaccine initiation or Tdap vaccine initiation.  
Individuals residing in a state with 2 mechanisms for obtaining a non-medical exemption 
had 1.57 times the odds (95% CI: 1.03-2.39) of initiating MenACWY vaccination compared to 
those who resided in a state with no mechanisms of obtaining a non-medical exemption, but 
there was no significant association when comparing those residing in a state with 1 mechanism 
for obtaining a non-medical exemption with those residing in a state with no mechanisms for 
obtaining a non-medical exemption. Individuals residing in a state with difficult exemption 
requirements had higher odds of initiating MenACWY vaccination compared to those residing in 
states with easy exemption requirements (aOR: 1.30, 95% CI: 1.08-1.57) while there was no 
significant association when comparing those residing in states with exemption requirements of 
medium difficulty and those residing in states with easy vaccine exemptions.  
Those residing in a state with 1 mechanism for obtaining a non-medical exemption had 
1.63 times the odds (95% CI: 1.05-2.54) of initiating Tdap vaccination compared to those 
residing in a state with no mechanism for obtaining a non-medical exemption. There was no 
significant association when comparing those residing in a state with 2 mechanisms for obtaining 
non-medical exemptions and those residing in a state with no mechanisms. Compared to residing 
in a state with easy exemption requirements, residing in a state with exemption requirements of 
medium difficulty (aOR: 1.35, 95% CI: 1.02-1.78) and residing in a state with difficult 
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exemption requirements (aOR: 1.48, 95% CI: 1.20-1.82) both had higher odds of initiating Tdap 
vaccination. There was no association between initiating HPV vaccination and number of 
mechanisms for obtaining a non-medical exemption or ease of obtaining an exemption. 
Additionally, there was no association between being up-to-date for HPV vaccination and 
number of mechanisms for obtaining a non-medical exemption or ease of obtaining a vaccine 
requirement exemption. 
Missed opportunities  
After adjusting for all individual characteristics, it was found that those who resided in a 
state with a MenACWY vaccine requirement had 0.38 times the odds (95% CI: 0.31-0.47) of 
having a missed opportunity for MenACWY vaccination. A similar relationship held true for the 
relationship between having a missed opportunity for MenACWY and residence in a state with a 
MenACWY booster dose requirement (aOR: 0.75, 95% CI: 0.57-0.98).  
Additionally, those who resided in a state that had 2 mechanisms for obtaining non-
medical exemptions had 0.59 times the odds (95% CI: 0.35-0.99) of having a missed opportunity 
for MenACWY vaccination compared to those who resided in states that had no mechanisms. 
There was no significant association when comparing those who lived in a state with 1 
mechanism for obtaining non-medical exemptions and those who resided in a state with no 
mechanisms for obtaining non-medical exemptions. 
Adjusting for individual characteristics, those who resided in states with exemption 
requirements of medium difficulty had 1.32 times the odds (95% CI: 1.01-1.74) of having a 
missed opportunity for MenACWY compared to those who resided in states in with easy 
exemption requirements. However, there was not a significant association for the comparison 
between those who resided in states with difficult exemption requirements and those who resided 
in states with easy exemption requirements.  
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For missed opportunities for HPV vaccination, state school entry HPV vaccine 
requirements appear to having the largest impact on reducing missed those residing in a state that 
had an HPV vaccination requirement had 0.42 times the odds (95% CI: 0.23-0.62) of having a 
missed opportunity for HPV vaccination compared to those who resided in a state without such a 
requirement after adjusting for all individual characteristics. After adjusting for all individual 
characteristics, there was no association between having a missed opportunity for HPV 
vaccination and the other policy variables (Table 2).  
Discussion 
  For many reasons that may include wide-ranging school entry requirements and 
exemption polices that vary by state, coverage for adolescent vaccination can be suboptimal and 
missed opportunities for adolescent vaccination can occur, with individuals receiving a 
recommended vaccine but not another that is recommended at the same visit. This may be a 
particular problem for HPV vaccination coverage as it lags behind that of the other adolescent 
vaccines, the MenACWY vaccine and the Tdap vaccine. To increase coverage, states may 
consider policy options, such as making obtaining a vaccine exemption more difficult, which 
may discourage getting one and prevent missed opportunities. However, before this action 
should be taken, it is important to understand how state vaccine policies may shape receipt of 
adolescent vaccines to get a sense of how effective of an intervention this may be. 
 Having school entry requirements for a specific adolescent vaccine is strongly associated 
with increased odds of initiating that vaccine. In the case of HPV vaccination, it was also 
strongly associated with completion of the vaccine series.  This reflects a body of literature that 
has found similar results both for HPV and MenACWY vaccination, with the implementation of 
requirements for a given vaccine contributing to increases in coverage for that vaccine.21,22 This 
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is an unsurprising result, but it further validates the importance of school entry requirements 
serving as a possible means for increasing coverage of  adolescent vaccines.  
 When examining the impact of allowable non-medical exemption types, in general, we 
found a small yet positive association with higher coverage for states with at least one 
mechanism for non-medical exemption compared to those with none. However, in most cases, 
this association was not significant. This trend went in the opposite direction of what we 
hypothesized and what was observed in the literature around exemptions for childhood vaccines. 
One study examining exemption rates for kindergarten vaccines found that the non-medical 
exemption rate in states that allowed both philosophical and religious exemptions was 2.4 times 
higher than in states that only allowed religious exemptions.11 In our focus on adolescent 
vaccines, our results may indicate that the availability of non-medical exemptions may be less 
important for ensuring coverage for these vaccines compared to childhood vaccines.  
When examining the ease of obtaining a non-medical exemption, we saw a similar 
general trend, a positive association with higher coverage for states with harder exemption 
criteria. Again, though, most of the results were small but non-significant. This is the opposite of 
what we expected based on studies examining ease of exemption for childhood vaccines. For 
childhood vaccines, states with easier exemption requirements had exemption rates more than 
twice those of states with more difficult exemption requirements.23 Additionally, states with 
more difficult vaccine exemption requirements had lower incidences of pertussis compared to 
those that had less difficult ones.24  
As our study elucidates, a key piece of the challenge in understanding the link between 
exemption policies and its impact on coverage for adolescent vaccination is that much of the 
research, including that described above, has been focused on the impact of vaccine exemptions 
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on childhood vaccines. There is a dearth in the literature on the relationship between vaccine 
exemption policy and adolescent vaccination. Because of this, there is not a clear picture of how 
exemption requirements influence adolescent vaccine coverage. There may be a number of 
reasons why there may not be a relationship between exemption requirements and adolescent 
vaccination rates. One may be that school entry vaccination requirements may not be as readily 
enforced for adolescent vaccines as for childhood vaccines. Previous research suggests that 
inconsistent school enforcement of state vaccination policies may be contributing to lower 
vaccine coverage.25 Another possibility is that as there are fewer vaccines for adolescents who 
are also seen by health care providers less frequently; therefore, it may be easier to get by 
without having follow-up about the vaccines. This has also played in the literature, with many 
adolescents not have primary care visits and fewer than half receiving preventive care.26 A third 
possibility is that by adolescence, parents may already be familiar with the process of obtaining 
an exemption so the difficulty of obtaining one may have less of an impact. 
We did not observe any spillover effects in our study, with requirements for the other 
adolescent vaccines being associated with lower odds of coverage for a particular adolescent 
vaccine. These effects were small and often non-significant. Previous research has shown a 
spillover effect wherein having a requirement for one of the adolescent vaccines can result in 
higher rates of the other adolescent vaccines. A study found that Tdap vaccine and MenACWY 
vaccine requirements were associated with 8 and 4 percentage point spillover increases in HPV 
vaccination coverage.9 It is possible that spillover effects are time-limited. For instance, spillover 
effects may be more likely when a new adolescent vaccine is recommended as discussion with 
providers about new vaccines may result in checking if the patient is up-to-date for other 
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adolescent vaccines. As time goes on, less frequent discussion of the new vaccine may result in 
less checking of the status of a patient’s immunization record. 
 When examining the outcome of missed opportunities, those residing in a state with a 
school entry requirement for a given vaccine were less likely to have a missed opportunity for 
that vaccine. No other policy variable was associated with reducing missed opportunities for 
adolescent vaccines. This is an important finding to consider when discussing policy measures 
for lowering rates of missed opportunities. Previous research has focused on the effectiveness of 
individual- and provider-level means of reducing missed opportunities, such as patient tracking 
and education and provider prompts.27 As policy interventions begin to be discussed more as 
another way of reducing missed opportunities, considering which components of state 
vaccination policies should be changed becomes an important consideration. 
Our study provides some evidence to be considered when making recommendations 
around state vaccination policies for adolescent vaccines. Further research needs to be done 
around the relationship between exemption policies and adolescent vaccination. Because of this, 
school entry requirements appear to be the most effective policy tool for increasing coverage and 
reducing missed opportunities. States would need to assess the feasibility and readiness for such 
policy changes on a case-by-case basis. There will likely be some pushback to instituting these 
requirements, especially for HPV vaccination. However, there is growing evidence that parents 
may be amenable to these changes with some studies showing increasing support.28 
 Our study had a few limitations that are important to consider along with our results. One 
limitation is that the provider-verified data were reliant on those taking the survey to be willing 
and able to recall and name all providers who may have delivered vaccines. While the provider 
verification ensured that the self-reported number of vaccines received could be validated, 
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receipt of a vaccine only could be validated in records that were obtainable. This, however, is 
likely to be non-differential so it is unlikely to have biased the results. Our study was also cross-
sectional in nature, only looking at one year of survey data. In order to observe if changes in 
policies would have an impact on coverage and missed opportunities for adolescent vaccination, 
longitudinal data would need to be collected and analyzed. This presents an opportunity for 
further research. A final limitation is that the ease of exemption variable we created could be 
seen as somewhat subjective based on the criteria we chose to judge the states’ exemption 
processes. To counter some of this perceived subjectivity, we validated the information collected 
from the state immunization websites against data collected by the CDC Public Health Law 
Program to ensure accuracy. The hierarchy of criteria was modeled off a study that used a similar 
variable to judge ease of vaccine exemption to check consistency with similar variables in the 
literature.   
Conclusions 
School entry vaccine requirements still remain the strongest policy means for increasing 
coverage although their spillover effects may be declining. However, in contrast to childhood 
vaccines, exemption requirements and the ease of obtaining a vaccine exemption may not be 
significant drivers of the lack of coverage for adolescent vaccination. There is a lack of research 
on the relationship of vaccine exemption policy and adolescent vaccination to explain why these 
policies may be less important, such as exploring school enforcement of policies or parent 
familiarity with these policies. More work needs to be done to look at the feasibility of 





Table 1. Individual and policy characteristics for included sample who had provider-verified 
vaccination data 
 
Individual Characteristics (N=20949) 
 N Weighted N % 
Age    
13 4283 4176574 20 
14 4429 4104984 19.7 
15 4212 4370416 21 
16 4218 4337415 20.8 
17 3807 3844092 18.5 
Mother's Age    
<=34 years 1599 1751308 8.4 
35 to 44 years 8447 8909298 42.8 
>=45 years 10903 10172575 48.8 
Census Region    
Northeast 3975 3406885 16.4 
Midwest 4485 4447131 21.3 
South 8032 8000078 38.4 
West 4457 4979087 23.9 
Mother's Education Level    
Less than 12 Years 2559 2742980 13.2 
12 Years 3139 4610862 22.1 
More than 12 Years, Non-College Grad 5173 4963605 23.8 
College Graduate 10078 8515734 40.9 
Poverty Status    
Above Poverty >$75K 10300 8554815 43.9 
Above Poverty <=$75K 6291 6668561 34.2 
Below Poverty 3579 4275442 21.9 
Marital Status of Mother    
Married 14791 13209334 63.4 
Not Currently Married 6158 7623847 36.6 
Race/Ethnicity    
Hispanic 3882 4927398 23.7 
NH White 13011 10897933 52.3 
NH Black 1742 2879031 13.8 
NH Other/Mixed Race 2314 2128820 10.2 
Sex    
Male 11104 10631199 51 
Female 9845 10201982 49 
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Insurance Status    
Private Insurance Only 11919 10518636 50.5 
Any Medicaid 6504 7819181 37.5 
Other Insurance 1708 1581348 7.6 
Uninsured 818 914017 4.4 
Facility Type for Provider    
All Public Facilities 2821 2988083 16 
All Hospital Facilities 2270 1831390 9.8 
All Private Facilities 9495 9994794 53.4 
All STD/School/Teen Clinics or Other Facilities 630 659921 3.5 
Mixed 3681 3258077 17.4 
Check-Up at 11 or 12    
Yes 16805 16518703 95.1 
No 836 848891 4.9 
Visits in Past 12 Months    
None 2816 3243992 15.8 
At Least 1 17922 17330871 84.2 
    
Policy Characteristics 
 N Weighted N % 
Meningitis Requirement    
Yes 11452 11641765 55.9 
No 9497 9191416 44.1 
Meningitis Booster Requirement    
Yes 3135 3165248 15.2 
No 17814 17667933 84.8 
HPV Requirement    
Yes 1050 612875 2.9 
No 19899 20220306 97.1 
Non-medical Exemption    
0 Mechanisms 996 2846172 13.7 
1 Mechanism 12269 10934839 52.5 
2 Mechanisms 7684 7052170 33.9 
Ease of Exemption    
Easy 5410 4937625 27.5 
Medium  3490 2698593 15 





Table 2. Crude and adjusted odds ratios for vaccine outcome variables with their 95% 
confidence intervals as predicted by policy variables. The full model adjusted for the following 
demographic variables: age of teen, mother’s age, mother’s education level, poverty status, 
marital status of mother, race/ethnicity, sex, health insurance status, facility type where 
vaccinations where given, census region, whether the teen had a check-up at 11 or 12, and 
whether the teen had a doctor’s visit in the last 12 months. 
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 HPV UTD HPV Initiation 
 Crude OR (95% CI) Adjusted OR (95% CI) Crude OR (95% CI) Adjusted OR (95% CI) 
Meningitis Requirement 1.00 (0.84, 1.21) 0.80 (0.66, 0.98) 0.90 (0.80, 1.00) 0.88 (0.78, 1.00) 
Meningitis Booster Requirement 0.90 (0.75, 1.08) 0.75 (0.59, 0.94) 0.91 (0.81, 1.03) 0.92 (0.79, 1.08) 
HPV Requirement 1.49 (0.94, 2.37) 1.99 (1.04, 3.80) 1.85 (1.33, 2.58) 2.43 (1.64, 3.61) 
Non-medical Exemption     
1 Mechanism 1.19 (0.78, 1.82) 1.39 (0.84, 2.30) 0.81 (0.62, 1.06) 1.21 (0.88, 1.66) 
2 Mechanisms 1.06 (0.69, 1.62) 1.13 (0.68, 1.88) 0.77 (0.59, 1.01) 1.09 (0.79, 1.50) 
Ease of Exemption     
Medium  0.94 (0.76, 1.16) 1.17 (0.89, 1.53) 0.97 (0.85, 1.11) 1.03 (0.87, 1.22) 
Difficult 0.82 (0.69, 0.96) 1.11 (0.91, 1.35) 0.91 (0.82, 1.02) 1.08 (0.95, 1.23) 
 MenACWY Initiation Tdap Initiation 
 Crude OR (95% CI) Adjusted OR (95% CI) Crude OR (95% CI) Adjusted OR (95% CI) 
Meningitis Requirement 1.92 (1.65, 2.23) 1.82 (1.53, 2.18) 1.16 (0.96, 1.39) 0.90 (0.74, 1.10) 
Meningitis Booster Requirement 1.24 (1.05, 1.47) 1.10 (0.89, 1.36) 1.19 (0.99, 1.44) 0.75 (0.59, 0.94) 
HPV Requirement 0.86 (0.57, 1.29) 0.82 (0.51, 1.33) 1.11 (0.69, 1.79) 0.88 (0.50, 1.57) 
Non-medical Exemption     
1 Mechanism 1.42 (1.01, 2.00) 1.16 (0.77, 1.75) 1.80 (1.23, 2.65) 1.63 (1.05, 2.54) 
2 Mechanisms 1.52 (1.08, 2.14) 1.57 (1.03, 2.39) 1.32 (0.90, 1.95) 1.36 (0.87, 2.12) 
Ease of Exemption     
Medium  0.81 (0.68, 0.97) 0.97 (0.76, 1.22) 1.07 (0.87, 1.32) 1.35 (1.02, 1.78) 
Difficult 0.94 (0.81, 1.09) 1.30 (1.08, 1.57) 1.09 (0.93, 1.27) 1.48 (1.20, 1.82) 
 MenACWY Missed Opportunity HPV Missed Opportunity 
 Crude OR (95% CI) Adjusted OR (95% CI) Crude OR (95% CI) Adjusted OR (95% CI) 
Meningitis Requirement 0.41 (0.34, 0.49) 0.38 (0.31, 0.47) 1.19 (1.06, 1.33) 1.12 (0.98, 1.27) 
Meningitis Booster Requirement 0.76 (0.61, 0.94) 0.75 (0.57, 0.98) 1.13 (1.01, 1.28) 1.03 (0.87, 1.22) 
HPV Requirement 1.57 (1.00, 2.49) 1.55 (0.92, 2.62) 0.57 (0.40, 0.80) 0.42 (0.28, 0.62) 
Non-medical Exemption     
1 Mechanism 0.83 (0.54, 1.28) 0.99 (0.60, 1.65) 1.49 (1.12, 1.96) 0.90 (0.65, 1.24) 
2 Mechanisms 0.57 (0.37, 0.88) 0.59 (0.35, 0.99) 1.44 (1.09, 1.91) 0.99 (0.72, 1.36) 
Ease of Exemption     
Medium  1.44 (1.15, 1.81) 1.32 (1.01, 1.74) 1.05 (0.91, 1.21) 1.05 (0.88, 1.25) 
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Bivariate Analysis Results 
 Based on the bivariate analysis, being up-to-date for HPV vaccination was statistically 
significantly associated with age of teen, mother’s age, sex, health insurance status, facility type 
where vaccinations were given, census region, whether the teen had a check-up at age 11 or 12, 
and whether the teen had a visit in the last 12 months. Being up-to-date for HPV vaccination was 
associated with the ease of obtaining a vaccine exemption in their state of residence, with the 
highest rates of being up-to-date for those residing in states with easy exemption requirements 
(Table SC1a). 
 MenACWY vaccine initiation was statistically significantly associated with mother’s 
education level, poverty status, facility type where vaccinations were given, census region, 
whether the teen had a check-up at age 11 or 12, and whether the teen had a visit in the last 12 
months. MenACWY vaccine initiation was significantly associated with both residence in a state 
with a MenACWY vaccine requirement and residence in a state with a MenACWY booster dose 
requirement (Table SC1b).    
HPV vaccine initiation was statistically significantly associated with age of teen, 
mother’s age, mother’s education level, poverty status, marital status of mother, race/ethnicity, 
sex, health insurance status, census region, whether the teen had a check-up at age 11 or 12, and 
whether the teen had a visit in the last 12 months. HPV vaccine initiation was significantly 
associated with residence in a state with an HPV vaccine requirement (Table SC1c). 
Tdap vaccine initiation was statistically significantly associated with mother’s education 
level, facility type where the vaccine was given, census region, and whether the teen had a 
check-up at age 11 or 12. Tdap vaccine initiation was associated with the number of mechanisms 
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for obtaining a non-medical exemption, with Tdap initiation highest among those residing in 
states with 1 mechanism for obtaining a non-medical exemption (Table SC1d). 
Having a missed opportunity for MenACWY vaccination was statistically significantly 
associated with mother’s education level, facility type where vaccines were given, and census 
region. Having a missed opportunity for MenACWY vaccination was associated with residence 
in a state with a MenACWY vaccine requirement and residence in a state with a MenACWY 
booster dose requirement, with a higher percentage of those with a missed opportunity for 
MenACWY vaccination residing in states without these requirements. Having a missed 
opportunity for MenACWY vaccination was associated with the numbers of mechanisms a state 
of residence has for obtaining non-medical exemptions. Having a missed opportunity for 
MenACWY vaccination was associated with the ease of obtaining a vaccine exemption in their 
residence, with the highest percentage of having a missed opportunity for MenACWY 
vaccination was among those who residing in states with easy requirements of obtaining a 
vaccine exemption (Table SC1e).  
 Having a missed opportunity for HPV vaccination was statistically significantly 
associated with mother’s age, mother’s education level, poverty status, marital status of mother, 
race/ethnicity, sex, health insurance status, census region, and whether the teen had a visit in the 
last 12 months. It was also found to be associated with residence in a state with an HPV vaccine 
requirement, with the percentage of those with a missed opportunity for HPV vaccination higher 
in residents of states without a requirement. It was found to be associated with all other policy 





Table SC1a. Bivariate analysis of up-to-date (UTD) HPV vaccination and individual and policy 
variables 
 
UTD HPV-Individual  
 UTD HPV Not UTD HPV  
 N (%) N (%) P-value 
Age   0.0002 
13 1717 (71.5) 616 (28.5)  
14 2111 (80.6) 530 (19.4)  
15 2201 (81.3) 480 (18.7)  
16 2266 (81.8) 453 (18.2)  
17 2038 (79.8) 435 (20.2)  
Mother's Age   0.0001 
<=34 years 778 (73.3) 262 (26.7)  
35 to 44 years 4053 (77.0) 1105 (23.0)  
>=45 years 5502 (82.4) 1147 (17.6)  
Mother's Education Level   0.0657 
Less than 12 Years 1447 (78.0) 343 (22.0)  
12 Years 1535 (78.9) 401 (21.1)  
More than 12 Years, Non-College Grad 2348 (76.7) 681 (23.3)  
College Graduate 5003 (81.4) 1089 (18.6)  
Poverty Status   0.4123 
Above Poverty >$75K 5018 (80.3) 1130 (19.7)  
Above Poverty <=$75K 2923 (78.8) 800 (21.2)  
Below Poverty 1982 (77.8) 507 (22.2)  
Marital Status of Mother   0.1984 
Married 7085 (80.0) 1666 (20.0)  
Not Currently Married 3248 (78.0) 848 (22.0)  
Race/Ethnicity   0.2233 
Hispanic 2222 (78.8) 523 (21.2)  
NH White 6024 (80.5) 1459 (19.5)  
NH Black 915 (75.9) 262 (24.1)  
NH Other/Mixed Race 1172 (79.2) 270 (20.8)  
Sex   <0.0001 
Male 5038 (76.2) 1399 (23.8)  
Female 5295 (82.0) 1115 (18.0)  
Insurance Status   0.0101 
Private Insurance Only 5727 (80.8) 1300 (19.2)  
Any Medicaid 3509 (78.7) 862 (21.3)  
Other Insurance 794 (79.7) 228 (20.3)  
Uninsured 303 (63.7) 124 (36.3)  
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Facility Type for Provider   0.0158 
All Public Facilities 1274 (73.2) 431 (26.8)  
All Hospital Facilities 1248 (82.7) 251 (17.3)  
All Private Facilities 4878 (80.3) 1055 (19.7)  
All STD/School/Teen Clinics or Other Facilities 237 (73.3) 88 (26.7)  
Mixed 1821 (80.8) 439 (19.2)  
Census Region   <0.0001 
Northeast 2383 (85.2) 359 (14.8)  
Midwest 2183 (79.5) 544 (20.5)  
South 3660 (76.4) 1037 (23.6)  
West 2107 (79.0) 574 (21.0)  
Check-Up at 11 or 12   0.0016 
Yes 8957 (82.0) 1860 (18.0)  
No 259 (62.2) 137 (37.8)  
Visits in Past 12 Months   <0.0001 
None 1096 (69.8) 406 (30.2)  
At least 1 9123 (80.8) 2082 (19.2)  
    
UTD HPV-Policy  
 UTD HPV Not UTD HPV P-value 
 N (%) N (%)  
Meningitis Requirement   0.9659 
Yes 5737 (79.2) 1384 (20.6)  
No 4596 (79.2) 1130 (20.8)  
Meningitis Booster Requirement   0.2445 
Yes 1506 (77.7) 397 (22.3)  
No 8827 (79.5) 2117 (20.5)  
HPV Requirement   0.0559 
Yes 706 (84.9) 93 (15.1)  
No 9627 (79.0) 2421 (21.0)  
Non-medical Exemption   0.2223 
0 Mechanisms 398 (77.3) 134 (22.7)  
1 Mechanism 6156 (80.3) 1399 (19.7)  
2 Mechanisms 3779 (78.4) 981 (21.6)  
Ease of Exemption   0.0363 
Easy 2876 (81.6) 594 (18.4)  
Medium  1714 (80.5) 389 (19.5)  





Table SC1b. Bivariate analysis of MenACWY vaccine initiation and individual and policy 
variables 
 
MenACWY Initiation-Individual  
 0 >=1   
 N (%) N (%) P-value 
Age   0.224 
13 689 (15.8) 3594 (84.2)  
14 632 (13.3) 3797 (86.7)  
15 602 (14.2) 3610 (85.8)  
16 623 (12.5) 3595 (87.5)  
17 537 (14.8) 3270 (85.2)  
Mother's Age   0.117 
<=34 years 280 (17.1) 1319 (82.9)  
35 to 44 years 1310 (14.3) 7137 (85.7)  
>=45 years 1493 (13.4) 9410 (86.6)  
Mother's Education Level   0.0024 
Less than 12 Years 366 (12.7) 2193 (83.7)  
12 Years 530 (15.8) 2609 (84.2)  
More than 12 Years, Non-College Grad 893 (16.4) 4280 (83.6)  
College Graduate 1294 (12.3) 8784 (87.7)  
Poverty Status   0.0448 
Above Poverty >$75K 1360 (13.4) 8940 (86.6)  
Above Poverty <=$75K 1109 (16.0) 5182 (84.0)  
Below Poverty 504 (13.5) 3075 (86.5)  
Marital Status of Mother   0.6833 
Married 2136 (14.0) 12655 (86.0)  
Not Currently Married 947 (14.4) 5211 (85.6)  
Race/Ethnicity   0.7038 
Hispanic 489 (13.4) 3393 (86.6)  
NH White 2007 (14.7) 11004 (85.3)  
NH Black 244 (13.2) 1498 (86.8)  
NH Other/Mixed Race 343 (14.1) 1971 (85.9)  
Sex   0.8264 
Male 1607 (14.0) 9497 (86.0)  
Female 1476 (14.2) 8369 (85.8)  
Insurance Status   0.0813 
Private Insurance Only 1657 (13.7) 10262 (86.3)  
Any Medicaid 960 (14.2) 5544 (85.8)  
Other Insurance 272 (13.7) 1436 (86.3)  
Uninsured 194 (19.0) 624 (81.0)  
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Facility Type for Provider   <0.0001 
All Public Facilities 581 (17.5) 2240 (82.5)  
All Hospital Facilities 319 (15.3) 1951 (84.7)  
All Private Facilities 996 (11.0) 8499 (89.0)  
All STD/School/Teen Clinics or Other Facilities 171 (23.2) 459 (76.8)  
Mixed 530 (13.0) 3151 (87.0)  
Census Region   <0.0001 
Northeast 323 (7.5) 3652 (92.4)  
Midwest 624 (12.5) 3861 (87.5)  
South 1202 (15.7) 6830 (84.3)  
West 934 (17.5) 3523 (82.5)  
Check-Up at 11 or 12   <0.0001 
Yes 2113 (12.5) 14692 (87.5)  
No 236 (22.0) 600 (78.0)  
Visits in Past 12 Months   0.0101 
None 562 (17.1) 2254 (82.9)  
At least 1 2492 (13.6) 15430 (86.4)  
    
MenACWY Initiation-Policy 
 0 >=1  P-value 
 N (%) N (%)  
Meningitis Requirement   <0.0001 
Yes 1229 (10.6) 10223 (89.4)  
No 1854 (18.5) 7643 (81.4)  
Meningitis Booster Requirement   0.008 
Yes 357 (12.0) 2778 (88.0)  
No 2726 (14.5) 15088 (85.5)  
HPV Requirement   0.4858 
Yes 117 (16.0) 933 (84.0)  
No 2966 (14.1) 16933 (85.9)  
Non-medical Exemption   0.0864 
0 Mechanisms 231 (18.4) 765 (81.6)  
1 Mechanism 1849 (13.7) 10420 (86.3)  
2 Mechanisms 1003 (13.0) 6681 (87.0)  
Ease of Exemption   0.0759 
Easy 679 (12.7) 4731 (87.3)  
Medium  639 (15.2) 2851 (84.8)  





Table SC1c. Bivariate analysis of HPV vaccine initiation and individual and policy variables 
 
 
HPV Initiation-Individual  
 0 >=1   
 N (%) N (%) P-value 
Age   0.0016 
13 1653 (39.3) 2630 (60.7)  
14 1549 (34.9) 2880 (65.1)  
15 1363 (33.5) 2849 (66.5)  
16 1367 (32.7) 2851 (67.3)  
17 1224 (31.9) 2583 (68.1)  
Mother's Age   0.0141 
<=34 years 496 (29.8) 1103 (70.2)  
35 to 44 years 2927 (33.8) 5520 (66.2)  
>=45 years 3733 (35.9) 7170 (64.1)  
Mother's Education Level   <0.0001 
Less than 12 Years 650 (25.4) 1909 (74.6)  
12 Years 1080 (33.6) 2059 (66.4)  
More than 12 Years, Non-College Grad 1958 (37.0) 3215 (63.0)  
College Graduate 3468 (36.4) 6610 (63.6)  
Poverty Status   <0.0001 
Above Poverty >$75K 3640 (37.1) 6660 (62.9)  
Above Poverty <=$75K 2332 (37.4) 3959 (62.6)  
Below Poverty 935 (26.7) 2644 (73.3)  
Marital Status of Mother   <0.0001 
Married 5359 (36.8) 9432 (63.2)  
Not Currently Married 1797 (30.4) 4361 (69.6)  
Race/Ethnicity   <0.0001 
Hispanic 997 (25.5) 2885 (74.5)  
NH White 4896 (40.0) 8115 (60.0)  
NH Black 491 (30.0) 1251 (70.0)  
NH Other/Mixed Race 772 (33.1) 1542 (66.9)  
Sex   <0.0001 
Male 4123 (37.4) 6981 (62.6)  
Female 3033 (31.4) 6812 (68.6)  
Insurance Status   <0.0001 
Private Insurance Only 4298 (37.5) 7621 (62.5)  
Any Medicaid 1886 (28.7) 4618 (71.3)  
Other Insurance 622 (38.0) 1086 (62.0)  
Uninsured 350 (42.5) 468 (57.5)  
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Facility Type for Provider   0.1967 
All Public Facilities 1007 (35.7) 1814 (64.3)  
All Hospital Facilities 642 (30.6) 1628 (69.4)  
All Private Facilities 3114 (33.6) 6381 (66.4)  
All STD/School/Teen Clinics or Other Facilities 277 (38.3) 353 (61.7)  
Mixed 1267 (33.2) 2414 (66.8)  
Census Region   <0.0001 
Northeast 1021 (29.7) 2954 (70.3)  
Midwest 1546 (35.3) 2939 (64.7)  
South 2998 (38.6) 5034 (61.4)  
West 1591 (30.5) 2866 (69.5)  
Check-Up at 11 or 12   0.0288 
Yes 5234 (32.1) 11571 (67.9)  
No 382 (38.8) 454 (61.2)  
Visits in Past 12 Months   0.0005 
None 125 (39.8) 1581 (60.2)  
At least 1 5864 (33.6) 12058 (66.4)  
    
HPV Initiation-Policy 
 0 >=1  P-value 
 N (%) N (%)  
Meningitis Requirement   0.055 
Yes 3813 (35.5) 7639 (64.5)  
No 3343 (33.1) 6154 (66.9)  
Meningitis Booster Requirement   0.124 
Yes 1084 (36.2) 2051 (63.8)  
No 6702 (34.2) 11742 (65.8)  
HPV Requirement   <0.0001 
Yes 199 (22.4) 851 (77.6)  
No 6957 (34.8) 12942 (65.2)  
Non-medical Exemption   0.1079 
0 Mechanisms 422 (30.1) 574 (68.9)  
1 Mechanism 4143 (34.7) 8126 (65.3)  
2 Mechanisms 2591 (35.9) 5093 (64.1)  
Ease of Exemption   0.2147 
Easy 1691 (33.9) 3719 (66.1)  
Medium  1235 (34.5) 2255 (65.5)  





Table SC1d. Bivariate analysis of Tdap vaccine initiation and individual and policy variables 
 
 
Tdap Initiation-Individual  
 0 >=1   
 N (%) N (%) P-value 
Age   0.0999 
13 559 (13.6) 3724 (86.4)  
14 495 (10.1) 3934 (89.9)  
15 439 (10.6) 3773 (89.4)  
16 451 (10.3) 3767 (89.7)  
17 396 (11.9) 3411 (88.1)  
Mother's Age   0.1098 
<=34 years 209 (13.1) 1390 (86.9)  
35 to 44 years 1001 (12.0) 7446 (88.0)  
>=45 years 1130 (10.4) 9773 (89.6)  
Mother's Education Level   0.0295 
Less than 12 Years 320 (12.1) 2239 (87.9)  
12 Years 399 (12.0) 2740 (88.0)  
More than 12 Years, Non-College Grad 614 (12.7) 4559 (87.3)  
College Graduate 1007 (9.8) 9071 (90.2)  
Poverty Status   0.0721 
Above Poverty >$75K 1004 (10.2) 9296 (89.8)  
Above Poverty <=$75K 822 (12.5) 5469 (87.5)  
Below Poverty 417 (11.8) 3162 (88.2)  
Marital Status of Mother   0.2124 
Married 1601 (10.8) 13190 (89.2)  
Not Currently Married 739 (12.1) 5419 (87.9)  
Race/Ethnicity   0.0795 
Hispanic 469 (13.6) 3413 (86.4)  
NH White 1375 (10.3) 11636 (89.7)  
NH Black 211 (10.3) 1531 (89.7)  
NH Other/Mixed Race 285 (12.2) 2029 (87.8)  
Sex   0.8373 
Male 1220 (11.4) 9884 (88.6)  
Female 1120 (11.2) 8725 (88.8)  
Insurance Status   0.1905 
Private Insurance Only 1199 (10.5) 10720 (89.5)  
Any Medicaid 793 (12.2) 5711 (87.8)  
Other Insurance 202 (10.3) 1506 (89.7)  
Uninsured 146 (13.4) 672 (86.6)  
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Facility Type for Provider   <0.0001 
All Public Facilities 390 (12.5) 2431 (87.5)  
All Hospital Facilities 266 (12.6) 2004 (87.4)  
All Private Facilities 846 (9.8) 8649 (90.2)  
All STD/School/Teen Clinics or Other Facilities 145 (17.6) 485 (82.4)  
Mixed 275 (7.8) 3406 (92.2)  
Census Region   <0.0001 
Northeast 309 (7.7) 3666 (92.3)  
Midwest 450 (9.4) 4035 (90.6)  
South 967 (11.5) 7065 (88.5)  
West 614 (15.1) 3843 (84.9)  
Check-Up at 11 or 12   0.0153 
Yes 1632 (10.2) 15173 (89.8)  
No 164 (16.1) 672 (83.9)  
Visits in Past 12 Months   0.0897 
None 427 (13.0) 2389 (87.0)  
At least 1 1885 (11.0) 16037 (89.0)  
    
Tdap Initiation-Policy 
 0 >=1  P-value 
 N (%) N (%)  
Meningitis Requirement   0.1291 
Yes 1271 (10.6) 10181 (89.4)  
No 1069 (12.1) 8428 (87.9)  
Meningitis Booster Requirement   0.0585 
Yes 315 (9.9) 2820 (90.1)  
No 2025 (11.5) 15789 (88.5)  
HPV Requirement   0.6514 
Yes 110 (10.3) 940 (89.7)  
No 2230 (11.3) 17669 (88.7)  
Non-medical Exemption   <0.0001 
0 Mechanisms 124 (15.8) 872 (84.2)  
1 Mechanism 1281 (9.4) 10988 (90.6)  
2 Mechanisms 935 (12.4) 6749 (87.6)  
Ease of Exemption   0.5875 
Easy 610 (11.1) 4800 (88.9)  
Medium  395 (10.5) 3095 (89.5)  





Table SC1e. Bivariate analysis of missed opportunities for MenACWY vaccination and 
individual and policy variables 
 
MenACWY Missed Opportunity-Individual  
 0 1 P-value 
 N (%) N (%)  
Age   0.2691 
13 3956 (92.9) 327 (7.1)  
14 4084 (92.2) 345 (7.8)  
15 3841 (90.8) 371 (9.2)  
16 3829 (91.7) 389 (8.3)  
17 3455 (90.6) 352 (9.4)  
Mother's Age   0.6174 
<=34 years 1445 (90.6) 154 (9.4)  
35 to 44 years 7696 (91.8) 751 (8.2)  
>=45 years 10024 (91.7) 879 (8.3)  
Mother's Education Level   0.0072 
Less than 12 Years 2359 (93.2) 200 (6.8)  
12 Years 2840 (90.3) 299 (9.7)  
More than 12 Years, Non-College Grad 4645 (90.0) 528 (10.0)  
College Graduate 9321 (92.8) 757 (7.2)  
Poverty Status   0.2124 
Above Poverty >$75K 9500 (92.3) 800 (7.7)  
Above Poverty <=$75K 5658 (90.9) 633 (9.1)  
Below Poverty 3290 (91.5) 289 (8.5)  
Marital Status of Mother   0.4588 
Married 13549 (91.9) 1242 (8.1)  
Not Currently Married 5616 (91.2) 542 (8.8)  
Race/Ethnicity   0.6766 
Hispanic 3616 (92.5) 266 (7.5)  
NH White 11824 (91.4) 1187 (8.6)  
NH Black 1593 (90.8) 149 (9.2)  
NH Other/Mixed Race 2132 (92.0) 182 (8.0)  
Sex   0.4801 
Male 10194 (91.9) 910 (8.1)  
Female 8971 (91.4) 874 (8.6)  
Insurance Status   0.6818 
Private Insurance Only 10918 (91.9) 1001 (8.1)  
Any Medicaid 5952 (91.3) 552 (8.7)  
Other Insurance 1560 (92.4) 148 (7.6)  
Uninsured 735 (90.4) 83 (9.6)  
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Facility Type for Provider   0.0376 
All Public Facilities 2472 (89.8) 349 (10.2)  
All Hospital Facilities 2094 (91.3) 176 (8.7)  
All Private Facilities 8877 (93.0) 618 (7.0)  
All STD/School/Teen Clinics or Other Facilities 560 (88.3) 70 (11.7)  
Mixed 3301 (91.4) 380 (8.6)  
Census Region   <0.0001 
Northeast 3778 (95.1) 197 (4.9)  
Midwest 4131 (92.6) 354 (7.4)  
South 7354 (90.4) 678 (9.6)  
West 3902 (90.4) 555 (9.6)  
Check-Up at 11 or 12   0.0536 
Yes 15483 (92.0) 1322 (8.0)  
No 720 (88.1) 116 (11.8)  
Visits in Past 12 Months   0.3639 
None 2556 (90.8) 260 (9.2)  
At least 1 16412 (91.8) 1510 (8.2)  
    
MenACWY Missed Opportunity-Policy 
 0 1 P-value 
 N (%) N (%)  
Meningitis Requirement   <0.0001 
Yes 10873 (94.7) 579 (5.3)  
No 8292 (87.8) 1205 (12.2)  
Meningitis Booster Requirement   0.0078 
Yes 2955 (93.3) 180 (6.7)  
No 16210 (91.4) 1604 (8.6)  
HPV Requirement   0.0989 
Yes 970 (87.6) 80 (12.4)  
No 18195 (91.8) 1704 (8.2)  
Non-medical Exemption   <0.0001 
0 Mechanisms 833 (89.3) 163 (10.7)  
1 Mechanism 11126 (91.0) 1143 (9.0)  
2 Mechanisms 7206 (93.7) 478 (6.3)  
Ease of Exemption   0.0071 
Easy 5075 (93.1) 335 (6.8)  
Medium  3075 (90.4) 415 (9.6)  





Table SC1f. Bivariate analysis of missed opportunities for HPV vaccination and individual and 
policy variables 
 
HPV Missed Opportunity-Individual  
 0 1 P-value 
 N (%) N (%)  
Age   0.2315 
13 2992 (69.5) 1291 (30.5)  
14 3167 (70.6) 1262 (29.4)  
15 3080 (71.5) 1132 (28.5)  
16 3085 (71.6) 1133 (28.4)  
17 2768 (73.5) 1039 (26.5)  
Mother's Age   <0.0001 
<=34 years 1229 (77.9) 370 (22.1)  
35 to 44 years 6079 (72.3) 2368 (27.7)  
>=45 years 7784 (69.2) 3119 (30.8)  
Mother's Education Level   <0.0001 
Less than 12 Years 2075 (80.4) 484 (19.6)  
12 Years 2290 (72.5) 849 (27.5)  
More than 12 Years, Non-College Grad 3580 (69.4) 1593 (30.6)  
College Graduate 7147 (68.8) 2931 (31.2)  
Poverty Status   <0.0001 
Above Poverty >$75K 7220 (68.6) 3080 (31.4)  
Above Poverty <=$75K 4435 (69.5) 1856 (30.5)  
Below Poverty 2859 (78.3) 720 (21.7)  
Marital Status of Mother   <0.0001 
Married 10326 (69.0) 4465 (31.0)  
Not Currently Married 4766 (75.2) 1392 (24.8)  
Race/Ethnicity   <0.0001 
Hispanic 3108 (80.5) 774 (19.5)  
NH White 8935 (66.1) 4076 (33.9)  
NH Black 1346 (74.0) 396 (26.0)  
NH Other/Mixed Race 1703 (73.0) 611 (27.0)  
Sex   <0.0001 
Male 7678 (68.5) 3426 (31.5)  
Female 7414 (74.2) 2431 (25.8)  
Insurance Status   <0.0001 
Private Insurance Only 8277 (68.0) 3642 (32.0)  
Any Medicaid 5926 (76.8) 1478 (23.2)  
Other Insurance 1210 (68.1) 498 (31.9)  
Uninsured 579 (66.9) 239 (33.1)  
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Facility Type for Provider   0.545 
All Public Facilities 2046 (71.6) 775 (28.4)  
All Hospital Facilities 1771 (76.0) 499 (24.0)  
All Private Facilities 6759 (70.4) 2736 (29.6)  
All STD/School/Teen Clinics or Other Facilities 454 (73.2) 176 (26.8)  
Mixed 2564 (71.2) 1117 (28.8)  
Census Region   <0.0001 
Northeast 3080 (73.0) 895 (27.0)  
Midwest 3209 (69.8) 1276 (30.2)  
South 5558 (67.6) 2474 (32.4)  
West 3245 (77.4) 1212 (22.6)  
Check-Up at 11 or 12   0.7246 
Yes 12362 (72.4) 4443 (27.6)  
No 574 (71.4) 262 (28.6)  
Visits in Past 12 Months   0.0252 
None 1883 (68.1) 933 (31.9)  
At least 1 13040 (71.8) 4882 (28.2)  
    
HPV Missed Opportunity-Policy 
 0 1 P-value 
 N (%) N (%)  
Meningitis Requirement   0.0026 
Yes 8289 (69.8) 3163 (30.2)  
No 6803 (73.3) 2694 (26.7)  
Meningitis Booster Requirement   0.0433 
Yes 2228 (69.1) 907 (30.9)  
No 12864 (71.7) 4950 (28.3)  
HPV Requirement   0.0003 
Yes 888 (81.2) 162 (18.8)  
No 14204 (71.0) 5695 (29.0)  
Non-medical Exemption   0.0123 
0 Mechanisms 642 (77.6) 354 (22.4)  
1 Mechanism 8832 (70.0) 3437 (30.0)  
2 Mechanisms 5618 (70.7) 2066 (29.3)  
Ease of Exemption   0.0674 
Easy 4063 (72.0) 1347 (28.0)  
Medium  2479 (71.0) 1011 (29.0)  
Difficult 7908 (69.3) 3145 (30.7)  
 
